L. Power

Distinct immune signatures discriminate SARS-CoV-2 vaccine combinations

B. Becher, C. Sotomayor, S. Unger, 2022, medRxiv.

A Hybrid Architecture (CO-CONNECT) to Facilitate Rapid Discovery and Access to Data Across the United Kingdom in Response to the COVID-19 Pandemic: Development Study

Shahzad Mumtaz, P. Quinlan, J. Baillie, 2022, Journal of medical Internet research.

Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England

H. Whitaker, S. Ladhani, L. Warrener, 2021, Journal of Infection.

Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March−June 2021, England

S. Ladhani, K. Brown, M. Ramsay, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.